Quarterly report pursuant to Section 13 or 15(d)

Schedule of Computation of Diluted Shares Outstanding (Details)

v3.22.1
Schedule of Computation of Diluted Shares Outstanding (Details) - shares
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 5,059,612 4,570,119
Common Stock Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 2,292,996 2,301,576
Common Stock Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 2,766,616 2,268,543